{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:46:03Z","timestamp":1772757963602,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jrnjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Renal Nutrition"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1053\/j.jrn.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T23:15:46Z","timestamp":1508454946000},"page":"470-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cystic Fibrosis: A Risk Condition for Renal Disease"],"prefix":"10.1053","volume":"27","author":[{"given":"Domenico","family":"Santoro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"Postorino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Lucanto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Cristadoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Conti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Buemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Magazz\u00f9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Bellinghieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.jrn.2017.05.006_bib1","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2215\/CJN.00750209","article-title":"Renal involvement in cystic fibrosis: diseases spectrum and clinical relevance","volume":"4","author":"Yahiaoui","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.05.006_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1681\/ASN.2006030269","article-title":"Cystic fibrosis is associated with a defect in apical receptor-mediated endocytosis in mouse and human kidney","volume":"18","author":"Jouret","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.jrn.2017.05.006_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1752-1947-1-24","article-title":"Cystic fibrosis and renal disease: a case report","volume":"1","author":"Al-Shawwa","year":"2007","journal-title":"J Med Case Rep"},{"key":"10.1053\/j.jrn.2017.05.006_bib4","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1164\/rccm.201105-0932OC","article-title":"Risk factors for chronic kidney disease in adults with cystic fibrosis","volume":"184","author":"Quon","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.jrn.2017.05.006_bib5","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1183\/09031936.00099506","article-title":"Cystic fibrosis mortality and survival in the UK: 1947-2003","volume":"29","author":"Dodge","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1053\/j.jrn.2017.05.006_bib6","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/ndt\/gfl067","article-title":"Factors increasing the risk for stone formation in adult patients with cystic fibrosis","volume":"21","author":"Terribile","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.jrn.2017.05.006_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ckj\/sft146","article-title":"Renal amyloidosis in cystic fibrosis: role of colchicine therapy","volume":"7","author":"Santoro","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1053\/j.jrn.2017.05.006_bib8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/thx.48.9.949","article-title":"Amyloidosis complicating cystic fibrosis","volume":"48","author":"Gaffney","year":"1993","journal-title":"Thorax"},{"key":"10.1053\/j.jrn.2017.05.006_bib9","first-page":"457","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function","volume":"109","author":"Stanton","year":"1997","journal-title":"Wien Klin Wochenschr"},{"key":"10.1053\/j.jrn.2017.05.006_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1590\/S0001-37652000000300013","article-title":"The cystic fibrosis transmembrane regulator (CFTR) in the kidney","volume":"72","author":"Morales","year":"2000","journal-title":"An Acad Bras Cienc"},{"key":"10.1053\/j.jrn.2017.05.006_bib11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1590\/S1806-37132009000700008","article-title":"Proteinuria in cystic fibrosis: a possible correlation between genotype and renal phenotype","volume":"35","author":"Cemlyn-Jones","year":"2009","journal-title":"J Bras Pneumol"},{"key":"10.1053\/j.jrn.2017.05.006_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jcf.2005.09.010","article-title":"Amyloidosis in cystic fibrosis: a case series","volume":"5","author":"Mc Laughlin","year":"2006","journal-title":"J Cyst Fibros"},{"key":"10.1053\/j.jrn.2017.05.006_bib13","first-page":"886","article-title":"Systemic amyloidosis in cystic fibrosis","volume":"131","author":"Ristow","year":"1977","journal-title":"Am J Dis Child"},{"key":"10.1053\/j.jrn.2017.05.006_bib14","first-page":"879","article-title":"Systemic amyloidosis complicating cystic fibrosis. a retrospective pathologic study","volume":"110","author":"McGlennen","year":"1986","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.jrn.2017.05.006_bib15","first-page":"37","article-title":"Review of eprodisate for the treatment of renal disease in AA amyloidosis","volume":"5","author":"Rumjon","year":"2012","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"10.1053\/j.jrn.2017.05.006_bib16","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1096\/fj.09-134981","article-title":"Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch","volume":"23","author":"Elimova","year":"2009","journal-title":"FASEB J"},{"key":"10.1053\/j.jrn.2017.05.006_bib17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1100\/tsw.2011.64","article-title":"Recent insights into the pathogenesis of type AA amyloidosis","volume":"11","author":"van der Hilst","year":"2011","journal-title":"ScientificWorldJournal"},{"key":"10.1053\/j.jrn.2017.05.006_bib18","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.24735","article-title":"Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview","volume":"61","author":"Obici","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1053\/j.jrn.2017.05.006_bib19","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/adc.66.12.1444","article-title":"Severe nephropathy in three adolescents with cystic fibrosis","volume":"66","author":"Melzi","year":"1991","journal-title":"Arch Dis Child"}],"container-title":["Journal of Renal Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105122761730122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105122761730122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T14:55:31Z","timestamp":1535295331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105122761730122X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S105122761730122X"],"URL":"https:\/\/doi.org\/10.1053\/j.jrn.2017.05.006","relation":{},"ISSN":["1051-2276"],"issn-type":[{"value":"1051-2276","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic Fibrosis: A Risk Condition for Renal Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Renal Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jrn.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}